Alum Apoorva Reddy leads new research revealing how CBD and THC differently influence sleep quality for people with cancer.
cancer
Fighting Tumors with Microbial Bile Acid
School of Pharmacy Assistant Professor Ting Fu and colleagues have identified a promising potential therapeutic lead for colorectal cancer.
Two PharmTox Students Earn Competitive Research Fellowships
PharmTox students are honored with Hilldale Fellowships, propelling their innovative research into Alzheimer’s and cancer.
School of Pharmacy Researchers Develop Personalized Cancer Vaccines that Slow Tumor Recurrence in Mice
Using a newly discovered byproduct of dying cancer cells, University of Wisconsin–Madison researchers are developing personalized vaccines that could help keep aggressive tumors from recurring.
Madison Alumni Gather to Talk Innovation
UW–Madison School of Pharmacy alumni and faculty share how they’ve been transforming patient outcomes, from opioids to heart failure and cancer care.
Leading Lab in Photos: Behind the Scenes in the Hong Lab
See the people, processes, and equipment behind Assistant Professor Cody Wenthur’s exploration into psychoactive substances.
New NIH Grant to Fight Triple-Negative Breast Cancer
With support from the NIH, Assistant Professor Quanyin Hu uses a two-step system to attack triple-negative breast cancer.
New Grant Fuels Pediatric Brain Cancer Treatments
With V Foundation funding, Assistant Professor Quanyin Hu aims to improve a cancer-killing hydrogel to improve outcomes for pediatric GBM patients.
UW Researchers Find Links Between Microbial Bile Acids and the Risk of Colon Cancer
UW researchers find previously unknown links between microbial bile acids and the risk of colon cancer.
Platelets as Protein Degraders
A cutting-edge platform developed by Assistant Professor Quanyin Hu uses protein-degrading platelets to suppress tumor regrowth and bolster immune response after surgery.